SG11201809537VA - Urea motif containing compounds and derivatives thereof as antibacterial drugs - Google Patents

Urea motif containing compounds and derivatives thereof as antibacterial drugs

Info

Publication number
SG11201809537VA
SG11201809537VA SG11201809537VA SG11201809537VA SG11201809537VA SG 11201809537V A SG11201809537V A SG 11201809537VA SG 11201809537V A SG11201809537V A SG 11201809537VA SG 11201809537V A SG11201809537V A SG 11201809537VA SG 11201809537V A SG11201809537V A SG 11201809537VA
Authority
SG
Singapore
Prior art keywords
international
compounds
miinchen
pct
derivatives
Prior art date
Application number
SG11201809537VA
Inventor
Philipp Kleiner
Stephan Sieber
Elena Kunold
Original Assignee
Univ Muenchen Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Muenchen Tech filed Critical Univ Muenchen Tech
Publication of SG11201809537VA publication Critical patent/SG11201809537VA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N47/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid
    • A01N47/08—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom not being member of a ring and having no bond to a carbon or hydrogen atom, e.g. derivatives of carbonic acid the carbon atom having one or more single bonds to nitrogen atoms
    • A01N47/28—Ureas or thioureas containing the groups >N—CO—N< or >N—CS—N<
    • A01N47/30—Derivatives containing the group >N—CO—N aryl or >N—CS—N—aryl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/32—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms
    • C07C275/34—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by singly-bound oxygen atoms having nitrogen atoms of urea groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/38—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by doubly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66—Nitrogen atoms not forming part of a nitro radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property MD 1101/110 111010101111101011111 0 01010 111H11111111111111111111111111111111111 Organization 0 International Bureau (10) International Publication Number (43) International Publication Date .....0\"\"\" WO 2017/207556 A2 07 December 2017 (07.12.2017) WIP0 I PCT (51) International Patent Classification: CO7D 317/62 (2006.01) A61K 31/17 (2006.01) A01N 47/30 (2006.01) (21) International Application Number: PCT/EP2017/063014 (22) International Filing Date: 30 May 2017 (30.05.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 16171906.7 30 May 2016 (30.05.2016) EP (71) Applicant: TECHNISCHE UNIVERSITAT MUNCHEN [DE/DE]; Arcisstr. 21, 80333 Miinchen (DE). (72) Inventors: KLEINER, Philipp; HardenbergstraBe 20, 80992 Miinchen (DE). SIEBER, Stephan; Olgartenweg 2, 86919 Utting am Ammersee (DE). KUNOLD, Elena; SchellingstraBe 106, 80798 Miinchen (DE). Agent: BOEHMERT & BOEHMERT ANWALTS- (74) PARTNERSCHAFT MBB; Markus Engelhard, Pet- tenkoferstraBe 20 - 22, 80336 Miinchen (DE). Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (81) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). (84) N Published: ..! — without international search report and to be republished V::+ upon receipt of that report (Rule 48.2(g)) in — in with sequence listing part of description (Rule 5.2(a)) IN 0 ei N (54) Title: UREA MOTIF CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS ANTIBACTERIAL DRUGS 1-1 0 (57) : The invention relates to compounds which are suitable for treating bacterial diseases and to pharmaceutical compositions \" containing such compounds. The invention further relates to a kit of parts comprising such compounds and to the use of such compounds 0 as disinfectants.
SG11201809537VA 2016-05-30 2017-05-30 Urea motif containing compounds and derivatives thereof as antibacterial drugs SG11201809537VA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16171906 2016-05-30
PCT/EP2017/063014 WO2017207556A2 (en) 2016-05-30 2017-05-30 Urea motif containing compounds and derivatives thereof as antibacterial drugs

Publications (1)

Publication Number Publication Date
SG11201809537VA true SG11201809537VA (en) 2018-12-28

Family

ID=56087197

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201809537VA SG11201809537VA (en) 2016-05-30 2017-05-30 Urea motif containing compounds and derivatives thereof as antibacterial drugs

Country Status (11)

Country Link
US (1) US20210009550A1 (en)
EP (1) EP3464260B8 (en)
JP (1) JP7129085B2 (en)
CN (1) CN109890804A (en)
CA (1) CA3023040A1 (en)
DK (1) DK3464260T3 (en)
ES (1) ES2901164T3 (en)
HU (1) HUE057798T2 (en)
PL (1) PL3464260T3 (en)
SG (1) SG11201809537VA (en)
WO (1) WO2017207556A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108026027B (en) * 2015-08-17 2020-10-02 邱浩杰 Substituted malonamide compounds and their use as antibacterial agents
CN108785306B (en) * 2018-09-09 2021-02-19 东北农业大学 Application of sorafenib in preparation of medicines for inhibiting bacteria and intervening pathogenic bacteria biofilm
CN109456261A (en) * 2018-12-05 2019-03-12 西安交通大学 A kind of light Affinity Probes molecule and preparation method thereof based on VEGFR-2 inhibitor Sorafenib
CN113061126A (en) * 2021-03-16 2021-07-02 无锡海伦生物科技有限公司 Preparation method and application of sorafenib photoaffinity probe molecule based on halogen intermediate
US11648248B1 (en) 2022-01-12 2023-05-16 King Abdulaziz University Potent antimicrobial compounds with a pyridazine nucleus
TW202339708A (en) * 2022-04-13 2023-10-16 國立臺灣大學 Antimicrobial compositions, pharmaceutical compositions and use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL254871A (en) * 1959-08-14
US3503886A (en) * 1967-10-27 1970-03-31 Mary C Noel Antiseptic compositions
WO1989000563A1 (en) * 1987-07-17 1989-01-26 The Nutrasweet Company High potency sweetening agents
JPH10109912A (en) * 1996-10-04 1998-04-28 Akio Suganuma Antimicrobial composition
US6207679B1 (en) * 1997-06-19 2001-03-27 Sepracor, Inc. Antimicrobial agents uses and compositions related thereto
US6093742A (en) * 1997-06-27 2000-07-25 Vertex Pharmaceuticals, Inc. Inhibitors of p38
US7517880B2 (en) 1997-12-22 2009-04-14 Bayer Pharmaceuticals Corporation Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
WO2000032196A2 (en) * 1998-12-04 2000-06-08 Influx, Inc. Inhibitors of multidrug transporters
AU2002243439A1 (en) 2000-11-17 2002-07-24 Smithkline Beecham Corporation Fatty acid synthase inhibitors
KR20030080509A (en) 2002-04-09 2003-10-17 주식회사 엘지생명과학 Antibacterial Compositions Containing Urea, Thiourea and Sulfamide Derivatives
JP2008518014A (en) * 2004-10-27 2008-05-29 ニューロゲン コーポレイション Diarylureas as CB1 antagonists
EP1991215A1 (en) 2006-03-09 2008-11-19 Cenix Bioscience GmbH Use of inhibitors of scavenger receptor class proteins for the treatment of infectious diseases
GB2449973B8 (en) 2007-05-31 2010-01-06 Syntopix Group Plc Antibacterial & anti-acne formulations containing dialkyl sulphosuccinates
WO2009035951A2 (en) 2007-09-11 2009-03-19 Arete Therapeutics, Inc. Soluble epoxide hydrolase inhibitors
WO2009088549A2 (en) 2007-10-19 2009-07-16 The Board Of Regents Of The University Of Texas System Methods of inhibiting bacterial virulence and compounds relating thereto
EP2385831A4 (en) 2009-01-09 2014-03-26 Uab Research Foundation Small molecule inhibitors of nads, namnat, and nmnat
CN103130686B (en) 2011-12-02 2016-09-14 天津市国际生物医药联合研究院 N, N '-asymmetric diaryl substitute urea compound and its production and use
WO2013142628A2 (en) 2012-03-20 2013-09-26 Fred Hutchinson Cancer Research Center Antibiotic compounds and compositions, and methods for identification thereof
US9951097B2 (en) * 2012-12-04 2018-04-24 The Board Of Trustees Of The University Of Illinois Antibacterial compounds targeting isoprenoid biosynthesis
WO2015051149A1 (en) 2013-10-04 2015-04-09 The Trustees Of Columbia University In The City Of New York Sorafenib analogs and uses thereof
US9387186B2 (en) 2014-05-22 2016-07-12 Muhammad Iqbal Choudhary Thiourea derivatives

Also Published As

Publication number Publication date
US20210009550A1 (en) 2021-01-14
HUE057798T2 (en) 2022-06-28
EP3464260B8 (en) 2022-02-16
WO2017207556A2 (en) 2017-12-07
WO2017207556A4 (en) 2018-03-22
ES2901164T3 (en) 2022-03-21
CA3023040A1 (en) 2017-12-07
EP3464260B1 (en) 2021-10-27
WO2017207556A3 (en) 2018-01-11
JP2019524644A (en) 2019-09-05
DK3464260T3 (en) 2021-12-20
CN109890804A (en) 2019-06-14
PL3464260T3 (en) 2022-01-31
JP7129085B2 (en) 2022-09-01
EP3464260A2 (en) 2019-04-10

Similar Documents

Publication Publication Date Title
SG11201809537VA (en) Urea motif containing compounds and derivatives thereof as antibacterial drugs
SG11201901700UA (en) Biaryl compounds useful as immunomodulators
SG11201908813QA (en) Anti-sirp alpha antibodies
SG11201805888SA (en) Cyclic dinucleotides for treating conditions associated with sting activity such as cancer
SG11201809559UA (en) Substituted pyridines as inhibitors of dnmt1
SG11201805940QA (en) Benzopyrazole compounds and analogues thereof
SG11201809064QA (en) Chimeric neurotoxins
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201901633WA (en) 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
SG11201907544VA (en) Jak inhibitors containing a 4-membered heterocyclic amide
SG11201906436VA (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201811442UA (en) Formulation of a peptide vaccine
SG11201908326YA (en) Methods of treating neurodegenerative diseases
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201902531QA (en) Liquid pharmaceutical composition
SG11201809499UA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11202000333UA (en) Bicyclic ketone compounds and methods of use thereof
SG11201804123VA (en) Modulators of kv3 channels to treat pain
SG11201907356SA (en) Piperidine-substituted mnk inhibitors and methods related thereto
SG11201903061YA (en) Combination treatments comprising administration of imidazopyrazinones
SG11201908691PA (en) Compounds and methods for the treatment of parasitic diseases
SG11201809497RA (en) Processes for preparing phosphorodiamidate morpholino oligomers
SG11201908918WA (en) Novel pyridazinone herbicides
SG11201804885TA (en) Monomaleimide-functionalized platinum compounds for cancer therapy
SG11201901850XA (en) Dopamine-b-hydroxylase inhibitors